Researchers have discovered a chemical messenger that promotes tumour growth in bowel and stomach cancers.
A drug that’s already being used for migraines could be repurposed to switch it off.
It’s early days, but scientists are hoping this leads to a targeted treatment that improves survival rates.
Guest/s
- Dr Pavitha Parathan, postdoctoral researcher at the Olivia Newton-John Cancer Research Institute
References
